Scott Ward serves on ImpediMed’s Nomination Committee and Remuneration Committee. Mr. Ward is a Managing Director at SightLine Partners, a venture capital firm focused on direct, secondary investments in later-stage medical device companies. He is also President of Raymond Holdings, a firm founded in 2011, with activities in venture capital, strategy and transactional advisory services.
Mr. Ward has over 30 years of experience in the healthcare industry, including 15 years as an operating business leader. He was most recently Senior Vice President and President of the Cardiovascular business of Medtronic Inc., responsible for all worldwide operations of the Cardiovascular Business including the Coronary, Peripheral, Endovascular, Structural Heart Disease and Revascularization and Surgical Therapies Businesses. Previously, Mr. Ward served as Senior Vice President and President of Medtronic Neurological and Diabetes, with responsibility for the global Neurological, Neurologic Technologies, Diabetes, Gastroenterology and Urology businesses; Vice President and General Manager of the Medtronic Drug Delivery Business; and Director of Medtronic NeuroVentures.
Mr. Ward is Chairman of the Board of Creganna-Tactx Medical Devices, Gillette Children’s Specialty Healthcare and Surmodics, Inc. He is also serves on the Board of Cardiovascular Systems Inc. He received his Bachelor’s Degree in Genetics and Cell Biology in 1981, and his Masters Degree in Toxicology in 1983, both from the University of Minnesota.
Listed company directorships held since 01 July 2011: